CDK2 and acute myeloid leukemia: Inactivation of cyclin-dependent kinase 2(CDK2), which overcomes the differentiation arrest of acute myeloid leukemia(AML) cells, maybe a promising approach for the treatment of AML.289–291 However, there are no available selective CDK2 inhibitors.292,293